Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. NVDA
8. PRIM
9. PFE
10. TSLA

Go back to Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Delayed: 4.10 --0 (-0%)
Previous Close $4.10    52 Week High $7.75 
Open $111.64    52 Week Low $3.61 
Day High $4.10    P/E N/A 
Day Low $4.10    EPS $-0.62 
Volume 6,812       

VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) Delayed: 23.40 --0 (-0%)
Previous Close $23.40    52 Week High $119.86 
Open $23.40    52 Week Low $13.77 
Day High $23.40    P/E N/A 
Day Low $23.40    EPS $0.00 
Volume 378,733       

VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) Delayed: 23.40 --0 (-0%)
Previous Close $23.40    52 Week High $119.86 
Open $23.40    52 Week Low $13.77 
Day High $23.40    P/E N/A 
Day Low $23.40    EPS $0.00 
Volume 378,733